Kidney dysfunction during lenalidomide treatment for AL amyloidosis

Bortezomib With or Without Dexamethasone in Primary Systemic (Light Chain) Amyloidosis

(2010) Efstathios Kastritis et al.   JOURNAL OF CLINICAL ONCOLOGY

Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study

(2009) D. E. Reece et al.   BLOOD

Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma

(2009) Christine Chen et al.   BRITISH JOURNAL OF HAEMATOLOGY

Amyloidosis: is a cure possible?

(2008) G. Merlini et al.   ANNALS OF ONCOLOGY

Azotemia associated with use of lenalidomide in plasma cell dyscrasias

(2008) Eric D. Batts et al.   LEUKEMIA & LYMPHOMA

Lenalidomide in Combination with Dexamethasone for the Treatment of Multiple Myeloma After One Prior Therapy

(2008) M. Hazarika et al.   ONCOLOGIST